Tag: Import Substitution

Dalkhimpharm conducts large-scale modernization

dalkhimfarm
A large-scale modernization aimed at expanding production facilities and manufacturing competitive products has began at Dalkhimpharm plant.

Nativa won a patent dispute with Bristol-Myers Squibb with regard to dasatinib

Patent
The Arbitration Court of the Moscow region decided to fully reject the claims filed by Bristol-Myers Squibb Holdings Ireland against Nativa LLC under the case No. A41-87845/2017.

Belarus developed the technology of obtaining povidone iodine

belaseptika
Belarus developed a technology for obtaining a pharmaceutical substance that can be used for manufacturing iodine-based medicines, announced Maria Sekach, Commercial Director of Belaseptika CJSC.

First Russian intradermal implant obtained registration

pharma
The first Russian intradermal implant has successfully passed the state registration. This product has been developed over the past three years with the support of the Russian Ministry of Industry and Trade.

Titanium Valley resident starts manufacturing of medical devices for neurosurgery

zibus
Zibus, a company, launched a production facility to manufacture titanium implants and neurosurgery tools in the Titanium Valley Special Economic Zone (SEZ) located in the Sverdlovsk region.

Prosthetic implants production facility was launched in Rameyev Technopark

rameev
In the future, once the enterprise reaches its production capacity, it will employ only local specialists from Penza. The program provides for gradual increase of production capacity over a two-year period.

Participants of Russian industrial clusters will receive subsidies

pharma manufacturing
Pharmaceutical companies participating in an industrial cluster can receive subsidies for up to 50% of their costs incurred for the implementation of joint cluster projects.

Russian drugs displace imports from the market

drugs
The first shifts in import substitution and expansion of innovative pharmaceutical production facilities occurred under Pharma - 2020, a state program which started as early as in 2011.

Russian company starts phase 2 clinical trials of its meningococcal vaccine

clinical trials
NPO Microgen has begun phase 2 clinical trials of the first Russian polysaccharide meningococcal vaccine to prevent diseases caused by Neisseria meningitidis serogroups A and C, including meningitis and meningococcemia.

Pharmstandard-Leksredstva will start manufacturing powders for pulmonary delivery

pharmstandard-leksredstva
The investment project to manufacture powders for pulmonary drug delivery involving the investment of more than 1.9 billion rubles will continue in 2018.

Manufacturing of nonwoven materials for medicine was launched in Tver region

hexa
Hexa – Nonwoven Materials LLC, a borrower of Industry Development Fund (IDF), has launched a new production facility for manufacturing high-tech specialized composite nonwoven materials

A new facility for blood plasma medicines will be established in St. Petersburg

plasma
On March 23, Noroorlovskaya Special Economic Zone in St. Petersburg will host an official ceremony marking the launch of construction of IMMUNO-GEM, a production facility for human blood plasma-derived medicines.

Kaluga is expected to complete its program for radiopharmaceuticals in two years

radiopharmaceutical drug
Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor expects that the region needs 2 years to complete its import substitution program for radiopharmaceuticals.

Russia plans to lift its ban on commercial cultivation of opium poppy

poppy
The Russian Ministry of Industry and Trade submitted to the government a draft law allowing cultivation of narcotic plants for pharmaceutical industry. This includes the opium poppy, which is used to manufacture painkillers.

Import substitution leads to growth of drug manufacturing in Russia

Drug Manufacturing
According to Rosstat, in 2017, the output of medicines was 12.3% higher than in 2016. The Russian Ministry of Industry and Trade said that output growth was facilitated by state support to Russian manufacturers.

Pharmstandard-Leksredstva will complete its project on asthma drugs in 2018

pharmstandard-leksredstva
In 2018, Pharmstandard-Leksredstva, a drug manufacturer, will launch the production of Russian-made medicines for asthma patients, announced the press office of the Kursk region administration. The pr...